There are 150 resources available
How to Make MSS Tumors More Sensitive for Immunotherapy
Presenter: Ryan Corcoran, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
BRAF Mutant Tumors: Strategy and New Data
Presenter: Scott Kopetz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
MOUNTAINEER: Open-label, phase 2 study of tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017)
Presenter: Jonathan Strickler, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100
Presenter: Hans Prenen, Belgium
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Rare Genomic Alterations Including Mutations and Fusions and Discussant
Presenter: Heinz-Josef Lenz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Measurement of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma (AA): prevalence, predictors, and correlation with clinical outcome
Presenter: Mohammad Zeineddine, United States
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
Resources:
Slides
PRRT in NET
Presenter: Christophe Deroose, Belgium
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
Resources:
Slides
GIST: Molecular Analysis and New Agents
Presenter: Jean-Yves Blay, France
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
Resources:
Slides
Anal Cancer: Role of IOs
Presenter: Cathy Eng, United States
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
Resources:
Slides
Concluding Remarks
Presenter: Eric Van Cutsem, Belgium; Josep Tabernero, Spain; Michel Ducreux, France
Session: Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer